|
|
|
PUBLISHED PAPERS Search these publications, which are sorted by year Fernandez-Aranda F, Pinheiro AP, Thornton L, Strober M, Berrettini WH, Crow S, Fichter MM, Halmi KA, Kaplan AS, Keel P, Mitchell J, Rotondo A, Woodside DB, Kaye WH, Bulik CM. Impulse control disorders in women with eating disorders. Psychiatry Research, 15;157(1-3):147-57, 2008. Reba-Harrelson L, Von Holle A, Thornton LM, Klump KL,
Berrettini WH, Brandt H, Crawford S, Crow S, Fichter MM, Goldman D, Halmi KA,
Johnson C, Kaplan AS, Keel P, LaVia M, Mitchell J, Rotondo A, Strober M,
Treasure J, Woodside DB, Kaye WH, Bulik CM. Features associated with diet
pill use in individuals with eating disorders. Eating Behaviors,
9(1):73-81, 2008. Wagner A, Aizenstein H, Mazurkewicz L, Fudge J, Frank GK, Putnam K, Bailer UF, Fischer L, Kaye WH. Altered insula response to taste stimuli in individuals recovered from restricting-type anorexia nervosa. Neuropsychopharmacology, 33(3):513-23, 2008. Frank GKW, Oberndorfer TA, Simmons AN, Paulus MP, Fudge JL, Yang TT, Kaye WH. Sucrose activates human taste pathways differently from artificial sweetner. NeuroImage 39: 1559-1569, 2008. Kaye WH, Bailer UF, Frank GK, Henry S, Price J, Meltzer C, Becker C, Ziolko S, Mathis C, Wagner A, Barbarich-Marstellar N, Putnam K. Serotonin transporter binding after recovery from eating disorders. Letter to the Editor. Psychopharmacoloy, January 3 2008 Epub ahead of print. Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Mathis
CA, Wagner A, Thornton L, Hoge J, Ziolko SK, Becker CR, McConaha CW, Kaye WH.
Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with
anorexia nervosa. Biological Psychiatry, 61(9):1090-1099, 2007. Frank GK, Bailer UF, Meltzer CC, Price J, Mathis C, Wagner
A, Becker C, Kaye WH. Regional cerebral blood flow after recovery from
anorexia and bulimia nervosa. International Journal of Eating Disorders,
40(6):488-492, 2007. Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Becker C, Ziolko S, Mathis CA, Wagner A, Barbarich-Marsteller NC, Putnam K, Kaye WH. Serotonin transporter binding after recovery from eating disorders. Psychopharmacology (Berl), 195(3):315-324, 2007. Frank GK, Wagner A, Brooks-Achenbach S, McConaha C, Skovira
K, Aizenstein H, Carter CS, Kaye WH. Altered brain activity in women
recovered from bulimic type eating disorders after a glucose challenge – A
pilot study. International Journal of Eating Disorders, 39(1):76-79,
2006. Wagner A, Greer P, Bailer UF, Frank GK, Henry SE, Putnam K,
Meltzer CC, Ziolko SK, Hoge J, McConaha C, Kaye WH. Normal brain tissue
volumes after long-term recovery in anorexia and bulimia nervosa.
Biological Psychiatry, 59(3):291-293, 2006. Wagner A, Barbarich N, Frank GK, Bailer UF, Weissfeld L,
Henry SE, Achenbach S, Vogel V, Plotnicov K, McConaha C, Kaye WH. Personality traits after recovery from eating disorders: Do subtypes
differ? International Journal of Eating Disorders, 39(4):276-284, 2006. Wagner A, Aizenstein H, Frank GK, Figurski J, May JC, Putnam K, Fischer L, Bailer UF, Henry SE, McConaha C, Vogel V, Kaye WH. Neural correlates of habituation to taste stimuli in healthy women. Psychiatry Research, 147(1):57-67, 2006. Kaye WH, Frank GK, Bailer UF, Henry SE. Neurobiology
of anorexia nervosa: Clinical implications of alterations of the function of
serotonin and other neuronal systems. International Journal of Eating
Disorders, Special Issue on Anorexia Nervosa. 37:S15-19; Discussion
S20-21, 2005 Kaye WH, Frank GK, Bailer UF, Henry SE, Meltzer CC, Price JC,
Mathis CA, Wagner A. Serotonin alterations in anorexia and bulimia nervosa:
new insights from imaging studies. Physiology & Behavior, 85(1):73-81,
2005. Lee M, Bailer UF, Frank GK, Henry SE, Meltzer CC, Price JC,
Mathis CA, Weissfeld L, Ferrell RE, Hariri AR, Kaye WH. Relationship of
a 5-HT transporter functional polymorphism to 5-HT1A receptor binding in
healthy women. Molecular Psychiatry, 10(8)715-716, 2005. Kaye WH, Bailer UF, Frank GK, Wagner A, Henry SE. Brain imaging of serotonin after recovery from anorexia and bulimia
nervosa.
Physiology & Behavior, 86(1-2):15-17, 2005. Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC,
Weissfeld L, Mathis CA, Drevets WC, Wagner A, Hoge, J, Ziolko S, McConaha CW,
Kaye WH. Altered brain serotonin 5-HT1A receptor binding after recovery
from anorexia nervosa measured by positron emission tomography and
[11C]WAY100635. Archives of General Psychiatry, 62(9):1032-1041, 2005. Frank GK, Kaye WH. Positron emission tomography
studies in eating disorders: Multireceptor brain imaging, correlates with
behavior and implications for pharmacotherapy. Nuclear Medicine &
Biology, 32(7):755-761, 2005. Frank GK, Bailer UF, Henry SE, Drevets W, Meltzer CC, Price JC, Mathis CA, Wagner A, Hoge J, Ziolko S, Barbarich N, Weissfeld L, Kaye WH. Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomorgraphy and [11C]Raclopride. Biological Psychiatry, 58(11):908-912, 2005. Barbarich NC, McConaha CM, Halmi KA, Gendall K, Sunday SR,
Gaskill J, La Via M, Frank GK, Brooks S, Plotnicov KH, Kaye WH. Use of
nutritional supplements to increase the efficacy of fluoxetine in the
treatment of anorexia nervosa. International Journal of Eating
Disorders, 35(1):10-15, 2004. Bailer UF, Price JC, Meltzer CC, Mathis CA, Frank GK,
Weissfeld L, McConaha CW, Henry SE, Brooks-Achenbach S, Barbarich NC, Kaye WH.
Altered 5-HT2A receptor activity after recovery from bulimia-type anorexia
nervosa: relationships to harm avoidance and drive for thinness.
Neuropsychopharmacology. 29(6):1143-1155, 2004. Agras WS, Brandt HA, Bulik CM, Dolan-Sewell R, Fairburn CG,
Halmi KA, Herzog DB, Jimerson DC, Kaplan AS, Kaye WH, le Grange D, Lock J,
Michell JE, Rudorfer MV, Street LL, Striegel-Moore R, Vitousek KM, Walsh BT,
Wilfley DE. Report of the National Institutes of Health workshop on
overcoming barriers to treatment research in anorexia nervosa.
International Journal of Eating Disorders, 35(4):509-521, 2004 Frank GK, Bailer UF, Wagner A, Henry S, Kaye, WH. Neuroimaging studies in eating
disorders. CNS Spectrums, 9(7):539-548,
2004. Kaye WH, Bulik CM, Thornton L, Barbarich N, Masters K,
Fichter MM, Halmi KA, Kaplan AS, Strober M, Woodside DB, Bergen AW, Crow S,
Mitchell J, Rotondo A, Mauri M, Cassano G, Keel P, Plotnicov K, Pollice C,
Klump KL, Lilenfeld LR, Devlin B, Quadflieg R, Berrettini WH. Comorbidity of anxiety disorders with anorexia and bulimia
nervosa. American
Journal of Psychiatry, 161(12):2215-2221, 2004. Bulik CM, Klump KL, Thornton L, Kaplan AS, Devlin B,
Fichter MM, Halmi KA, Strober M, Woodside DB, Crow S, Mitchell J, Rotondo A,
Mauri M, Cassano G, Keel P, Berrettini WH, Kaye WH. Alcohol use disorder
comorbidity of eating disorders: A multicenter study. Journal of
Clinical Psychiatry, 65:1000-1006, 2004. Barbarich NC, McConaha C, Gaskill J, LaVia M, Frank GK, Brooks S, Plotnicov K, Kaye WH. An open trial of olanzapine in anorexia nervosa. Journal of Clinical Psychiatry, 65:1480-1482, 2004. Barbarich
Bailer UF, Kaye WH. A review of neuropeptide and
neuroendocrine dysregulation in anorexia and bulimia nervosa. Current
Drug Targets: CNS and Neurological Disorders, 2(1):53-60, 2003 Malina A, Gaskill J, McConaha C, Frank G, LaVia M, Scholar
L, Kaye WH. Olanzapine treatment of anorexia nervosa: A retrospective
study. International Journal of Eating Disorders, 33(2):234-237, 2003. Kaye WH, Barbarich NC, Putnam K, Gendall KA, Fernstrom J,
Fernstrom M, McConaha CW, Kishore A. Anxiolytic effects of acute
tryptophan depletion (ATD) in anorexia nervosa. International Journal of
Eating Disorders, 33(3):257-267, 2003. Stein D, Kaye WH. Pain perception in recovered bulimia
nervosa patients. International Journal of Eating Disorders,
34(3):331-336, 2003. Frank GK, Kaye WH, Carter CS, Brooks S, May C, Fissell K, Stenger
Stein
D, Kaye WH, Matsunaga H, Orbach I, Har-Even D, Frank G, McConaha CW, Rao R.
Eating related concerns, moods and personality traits in recovered bulimia
nervosa patients. A replication study. International Journal of Eating
Disorders. 32(2):225-229, 2002. Frank GK, Kaye WH, Meltzer CC, Price JC, Greer P, McConaha
C, Skovira K. Reduced 5-HT2A receptor binding after recovery from
anorexia nervosa. Biological Psychiatry, 52:896-906, 2002. Kaye WH, Nagata T, Weltzin TE, Hsu LKG, Sokol MS,
McConaha C, Plotnicov KH, Weise J, Deep D: Double-blind placebo-controlled
administration of fluoxetine in restricting- and restricting-purging-type
anorexia nervosa. Biological Psychiatry, 49(7):644-652, 2001. Frank GK, Kaye WH, Marcus M. Sertraline in underweight binge
eating/purging-type eating disorders - Five case reports. International
Journal of Eating Disorders, 29(4):495-498, 2001. Frank G, Kaye WH, Sahu A, Fernstrom J, McConaha C. Could
reduced CSF Galanin contribute altered taste related hedonics in anorexia
nervosa? Neuropsychopharmacology, 24(6):705-709, 2001. Frank GK, Kaye WH, Weltzin TE, Perel J, Moss H, McConaha C,
Pollice C: Altered response to m-CPP in anorexia nervosa: Support for a
persistent alteration of serotonin activity after short term weight
restoration. International Journal of Eating Disorders, 30(1):57-68,
2001. Kaye WH, Frank GK, Meltzer CC, Price JC, McConaha CW,
Crossan PJ, Klump KL, Rhodes L: Altered serotonin 2A receptor activity in
women who have recovered from bulimia nervosa. American Journal of
Psychiatry, 158(7):1152-1155, 2001. Nagata T, Kaye WH, Kiriike N, Rao R, McConaha C, Plotnicov
KH. Physical and sexual abuse histories in patients with eating
disorders: A comparison of Japanese and American patients. Psychiatry
& Clinical Neurosciences, 55:333-340, 2001. Frank
G, Kaye WH, Ladenhiem EE, McConaha C. Reduced gastrin releasing peptide
in CSF after recovery from bulimia nervosa. Appetite, 37:871-879, 2001. Kaye
WH, Gendall K, Srober M. Nutrition, serotonin and behavior in anorexia
and bulimia nervosa. Discussion. Nestle Nutr Workshop Ser Clin
Perform Programme (5):153-155, 2001. Strober M, Freeman R,
Lampert C, Diamond J, Kaye W: A controlled family study of anorexia nervosa
and bulimia nervosa: Evidence of shared liability and transmission of partial
syndromes. American Journal of Psychiatry, 157:393-401, 2000. Kaye WH, Gendall KA,
Fernstrom MH, Fernstrom JD, McConaha CW, Weltzin TE: Effects of acute
tryptophan depletion on mood in bulimia nervosa. Biological Psychiatry,
47(2):151-157, 2000. La Via MC, Gray N, Kaye
WH: Case reports of olanzapine treatment of anorexia
nervosa.
International Journal of Eating Disorders, 27(3):363-366, 2000. Matsunaga H, Kiriike N,
Iwasaki Y, Miyata A, Matsui T, Nagata T, Yamagami S, Kaye WH:
Multi-impulsivity among bulimic patients in Japan. International Journal
of Eating Disorders, 27(3):348-352, 2000. Matsunaga H, Kaye
WH, McConaha C, Plotnicov K, Pollice C, Rao R: Personality disorders among
subjects recovered from eating disorders. International Journal of Eating
Disorders, 27(3):353-357, 2000. Frank GKW, Kaye WH,
Altemus A, Greeno C: CSF oxytocin and vasopressin levels after recovery from
bulimia nervosa: Association with comorbid obsessive and depressive disorders.
Biological Psychiatry, 48:315-318, 2000. Deep-Soboslay A,
Sebastiani LM, Kaye WH: Weight gain in anorexia nervosa: Efficacy of inpatient
and intensive outpatient treatment. American Journal of Psychiatry,
157(9):1526 Sept 2000. Meltzer CC, Cantwell MN,
Greer PJ, Ben-Eliezer D, Smith G, Frank G, Kaye WH, Houck PR, Price JC. Does cerebral blood flow decline in healthy aging? A PET study with
partial-volume correction. Journal of Nuclear Medicine, 41(11):1842-1948,
2000. Lilenfeld LRR, Stein D, Bulik CM, Strober M, Plotnicov K,
Pollice C, Rao R, Merikangas KR, Nagy L, Kaye WH: Personality traits among
currently eating disordered, recovered, and never ill first-degree female
relatives of bulimic and control women. Psychological Medicine,
30(6):1399-1410, 2000. Frank G, Kaye WH, Greer P, Meltzer C,
Price JC. Regional cerebral blood flow after recovery from bulimia
nervosa. Psychiatry Research: Neuroimaging. 100(1):31-39, 2000. Deep AL, Lilenfeld LR,
Plotnicov KH, Pollice C, Kaye WH: Sexual abuse in eating disorder subtypes and
control women: The role of comorbid substance dependence in bulimia nervosa.
International Journal of Eating Disorders, 25(1): 1-10, 1999. Ferguson CP, La Via MC,
Crossan PJ, Kaye, WH: Are SSRI’s effective in underweight anorexia nervosa?
International Journal of Eating Disorders, 25(1): 11-17, 1999. Kaye WH, Strober M,
Stein D, Gendall KA: New Directions in Treatment Research of Anorexia and
Bulimia Nervosa. Biological Psychiatry, 45(10):1285-1292, 1999. Matsunaga H, Kiriike Y,
Iwasaki Y, Miyata A, Yamagami S, Kaye WH: Clinical characteristics in patients
with anorexia nervosa and obsessive-compulsive disorder. Psychological
Medicine, 29(2): 407-414, 1999. Sokol MS, Gray NS,
Goldstein A, Kaye WH: Methylphenidate treatment for bulimia nervosa associated
with a cluster B personality disorder. International Journal of Eating
Disorders, 25(2): 233-237, 1999. Han L, Nielsen DA, Rosenthal NE, Jefferson K, Kaye W, Murphy D, Altemus M, Humphries J, Cassano G, Rotondo A, Virkkunen M, Linnoila M, Goldman D: No coding variant of the tryptophan hydroxylase gene detected in seasonal affective disorders, obsessive-compulsive disorders, anorexia nervosa and alcoholism. Biological Psychiatry, 45(5): 615-619, 1999. Gendall KA, Kaye WH,
Altemus M, McConaha CW, La Via MC: Leptin, NPY and PYY in long term recovered
eating disorders patients. Biological Psychiatry, 46(2): 292-299, 1999. Stein D, Lilenfeld L,
Plotnicov K, Pollice C, Rao R, Strober M, Kaye WH: Familial aggregation of
eating disorders: Results from a controlled family study of bulimia nervosa.
International Journal of Eating Disorders, 26(2): 211-215, 1999. Kaye WH, Frank GKW,
McConaha C: Altered dopamine activity after recovery from restricting-type
anorexia nervosa. Neuropsychopharmacology, 21(4): 503-506, 1999. Von Ranson KM, Kaye W,
Weltzin TE, Rao R, Matsunaga H: Obsessive-compulsive disorder symptoms before
and after recovery from bulimia nervosa. American Journal of Psychiatry,
156 (11): 1703-1708, 1999. Matsunaga H, Kiriike N,
Miyata A, Iwasaki Y, Matsui T, Fujimoto K, Kasai S, Kaye WH: Prevalence and
symptomatology of comorbid obsessive-compulsive disorder among bulimic
patients. Psychiatry and Clinical Neuroscience, 53(6): 661-666, 1999. Matsunaga H, Kaye WH,
McConaha C, Plotnicov K, Pollice C, Rao R, Stein D: Psychopathological
characteristics of recovered bulimics who have a history of physical or sexual
abuse. Journal of Nervous and Mental Disease, 187(8): 472-477, 1999. Enoch M, Kaye W, Ozaki N, Mazzanti C, Rotondo A, Greenberg B, Altemus M, Murphy D, Goldman D: 5-HT2A promoter polymorphism -1438G/A, anorexia nervosa, and obsessive-compulsive disorder. Lancet, 351(9118):1785-1786, 1998 Kaye W, Gendall K, Kye
C: The role of the central nervous system
in the psychoneuroendocrine disturbances of anorexia and bulimia nervosa.
Psychiatric Clinics of Kaye W, Gendall K,
Strober M: Serotonin neuronal
function and SSRI treatment in anorexia and bulimia nervosa.
Biological Psychiatry, 44:825-838, 1998. Kaye WH, Greeno CG, Moss
H, Fernstrom J, Fernstrom M, Lilenfeld LR, Weltzin TE, Mann J: Alterations
in serotonin activity and psychiatric symptoms after recovery from bulimia
nervosa. Archives of General Psychiatry, 55(10):927-935, 1998. Lilenfeld LR, Kaye WH,
Greeno CG, Merikangas KR, Plotnicov KH, Pollice CP, Rao R, Strober M, Bulik
CM, Nagy L: A controlled
family study of anorexia and bulimia nervosa: Psychiatric disorders in
first-degree relatives and effects of proband comorbidity. Archives
of General Psychiatry, 55(7):603-610, 1998.
|
